Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
- PMID: 12475782
- DOI: 10.2337/diabetes.51.2007.s394
Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
Abstract
Glucokinase (GK) serves as glucose sensor in pancreatic beta-cells and in other glucose sensor cells in the body. Biochemical genetic studies have characterized many activating and inactivating GK mutants that have been discovered in patients with hyperinsulinemic hypoglycemia or diabetes, all inherited as autosomal dominant traits. Mathematical modeling of the kinetic data of recombinant human wild-type and mutant GK accurately predicts the effects of GK mutations on the threshold of glucose-stimulated insulin release and glucose homeostasis. Structure/function studies of the enzyme suggest the existence of a hitherto unknown allosteric activator site of the enzyme that has significant implications for the physiological chemistry of GK-containing cells, particularly the pancreatic beta-cells. Glucose is the preeminent positive regulator of beta-cell GK expression and involves molecular mechanisms that are still to be elucidated in detail, but seem to have a specific requirement for increased glucose metabolism. Pharmaceutical chemists, motivated by the clear tenets of the GK glucose-sensor paradigm, have searched for and have discovered a novel class of GK activator molecules. The therapeutic application of this basic discovery offers a new principle for drug therapy of diabetes.
Similar articles
-
Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).Biochem J. 1999 Sep 1;342 ( Pt 2)(Pt 2):345-52. Biochem J. 1999. PMID: 10455021 Free PMC article.
-
Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.Handb Exp Pharmacol. 2011;(203):357-401. doi: 10.1007/978-3-642-17214-4_15. Handb Exp Pharmacol. 2011. PMID: 21484579 Review.
-
Glucokinase and glucose homeostasis: proven concepts and new ideas.Biochem Soc Trans. 2005 Feb;33(Pt 1):306-10. doi: 10.1042/BST0330306. Biochem Soc Trans. 2005. PMID: 15667334
-
Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.Diabetes. 1999 Aug;48(8):1645-51. doi: 10.2337/diabetes.48.8.1645. Diabetes. 1999. PMID: 10426385
-
Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.Diabetes. 1996 Feb;45(2):223-41. doi: 10.2337/diab.45.2.223. Diabetes. 1996. PMID: 8549869 Review.
Cited by
-
Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.PLoS One. 2012;7(4):e34541. doi: 10.1371/journal.pone.0034541. Epub 2012 Apr 6. PLoS One. 2012. PMID: 22493702 Free PMC article.
-
Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology.F1000Res. 2016 Jul 15;5:F1000 Faculty Rev-1711. doi: 10.12688/f1000research.8682.1. eCollection 2016. F1000Res. 2016. PMID: 27508066 Free PMC article. Review.
-
Restructuring of pancreatic islets and insulin secretion in a postnatal critical window.PLoS One. 2006 Dec 20;1(1):e35. doi: 10.1371/journal.pone.0000035. PLoS One. 2006. PMID: 17183663 Free PMC article.
-
Structure-function analysis of the alpha5 and the alpha13 helices of human glucokinase: description of two novel activating mutations.Protein Sci. 2005 Aug;14(8):2080-6. doi: 10.1110/ps.051485205. Epub 2005 Jun 29. Protein Sci. 2005. PMID: 15987895 Free PMC article.
-
The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism.Front Endocrinol (Lausanne). 2019 Feb 26;10:111. doi: 10.3389/fendo.2019.00111. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30873120 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
